← Leaderboards
Sihoun Hahn
Seattle Children'S Hospital
$9,588,424
Attributed
$10,399,806
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2010–25$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,399,806 · 7
By mechanism
R01$8,273,430 · 3
R21$1,578,348 · 3
R56$548,028 · 1
Top collaborators
- Michael H Gelb3 shared
Most similar at Seattle Children'S Hospital
Same institution · by research overlap
- Heather Leigh Herd Gustafson$2,399,099
Others in their field
Top investigators on “Blood”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David R. Weir · University Of Michigan At Ann Arbor$381,545,820
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$292,209,610
- Chanza Baytop · Westat, Inc.$271,217,917
- Mary M Horowitz · Medical College Of Wisconsin$240,114,780
Research focus
BloodEarly DiagnosisNeonatal ScreeningMass Spectrum AnalysisProteinsSamplingPeptidesSpottingsCost EffectiveScreeningHigh Throughput ScreeningHepatolenticular DegenerationProteomicsBaseLifeNewborn InfantCongenital DisordersAffectCongenital ImmunodeficiencyTandem Mass SpectrometryChildDisabilityHealth Care CostsBiological Markers
Grant awards (19)
Development of a Multiplex Proteomics Assay for High-Throughput Newborn Screening of a New Set of Treatable Neonatal Diseases$485,737
R01 · FY2025 · HD · contact PI
Development of a Multiplex Proteomics Assay for High-Throughput Newborn Screening of a New Set of Treatable Neonatal Diseases$553,803
R01 · FY2024 · HD · contact PI
Development of a Multiplex Proteomics Assay for High-Throughput Newborn Screening of a New Set of Treatable Neonatal Diseases$583,225
R01 · FY2023 · HD · contact PI
Multiplex Proteomic Analysis for Next-Generation Newborn Screening of Wilson Disease, Cystinosis, and Primary Immunodeficiencies$586,420
R01 · FY2022 · HD · contact PI
Multiplex Proteomic Analysis for Next-Generation Newborn Screening of Wilson Disease, Cystinosis, and Primary Immunodeficiencies$586,420
R01 · FY2021 · HD · contact PI
Multiplexed immuno-SRM screening for primary immunodeficiencies$794,530
R01 · FY2020 · AI · contact PI
Multiplex Proteomic Analysis for Next-Generation Newborn Screening of Wilson Disease, Cystinosis, and Primary Immunodeficiencies$492,959
R01 · FY2020 · HD · contact PI
Targeted Proteomic Analysis of Extremely Low Abundance Signature Peptide Biomarkers for Potential Newborn Screening in Wilson's Disease$235,375
R21 · FY2020 · HD · contact PI
Multiplexed immuno-SRM screening for primary immunodeficiencies$875,319
R01 · FY2019 · AI · contact PI
Multiplex Proteomic Analysis for Next-Generation Newborn Screening of Wilson Disease, Cystinosis, and Primary Immunodeficiencies$511,833
R01 · FY2019 · HD · contact PI
Targeted Proteomic Analysis of Extremely Low Abundance Signature Peptide Biomarkers for Potential Newborn Screening in Wilson's Disease$282,450
R21 · FY2019 · HD · contact PI
Multiplexed immuno-SRM screening for primary immunodeficiencies$908,996
R01 · FY2018 · AI · contact PI
Multiplexed immuno-SRM screening for primary immunodeficiencies$935,847
R01 · FY2017 · AI · contact PI
Multiplexed immuno-SRM screening for primary immunodeficiencies$958,341
R01 · FY2016 · AI · contact PI
Multiplex Test for Primary Immunodeficiencies by Affinity Column coupled to MS/MS$548,028
R56 · FY2014 · AI · contact PI
Peptide Immunoaffinity enriched LC-MRM-MS analysis for Cystinosis/Wilson disease$235,710
R21 · FY2014 · HD · contact PI
Peptide Immunoaffinity enriched LC-MRM-MS analysis for Cystinosis/Wilson disease$291,000
R21 · FY2013 · HD · contact PI
Peptide Fingerprint multiplex analysis by MS/MS for primary immundeficiency$241,313
R21 · FY2011 · AI · contact PI
Peptide Fingerprint multiplex analysis by MS/MS for primary immundeficiency$292,500
R21 · FY2010 · AI · contact PI